Francisco Javier Lucas Imbernón-rekin lankidetzan egindako argitalpenak (17)

2023

  1. Corrigendum to “Hyperkalemia in acute heart failure: Short term outcomes from the EAHFE registry” [American Journal of Emergency Medicine, 70C (2023) 1–9, (S0735675723002486), (10.1016/j.ajem.2023.05.005)]

    American Journal of Emergency Medicine

  2. Hyperkalemia in acute heart failure: Short term outcomes from the EAHFE registry

    American Journal of Emergency Medicine, Vol. 70, pp. 1-9

  3. Impact of congestion and perfusion status in the emergency department on severity of decompensation and short-term prognosis in patients with acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 3, pp. 165-174

  4. QT interval and short-term outcome in acute heart failure

    Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1754-1765

2022

  1. Impact of diabetes and on-arrival hyperglycemia on short-term outcomes in acute heart failure patients

    Internal and Emergency Medicine

  2. Short-term outcomes by chronic betablocker treatment in patients presenting to emergency departments with acute heart failure: BB-EAHFE

    European Heart Journal: Acute Cardiovascular Care, Vol. 11, Núm. 10, pp. 761-771

2021

  1. Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate

    Journal of Cardiology, Vol. 77, Núm. 3, pp. 245-253

  2. Correction to: Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study (Clinical Research in Cardiology, (2021), 110, 7, (993-1005), 10.1007/s00392-020-01710-0)

    Clinical Research in Cardiology

  3. Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study

    Clinical Research in Cardiology, Vol. 110, Núm. 7, pp. 993-1005

  4. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  5. Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019: A Case-Control, Emergency Medicine-Based Multicenter Study

    Chest, Vol. 159, Núm. 3, pp. 1241-1255

  6. Incidence, clinical characteristics, risk factors and outcomes of meningoencephalitis in patients with COVID-19

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 8, pp. 1645-1656

  7. The FAST-FURO study: Effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 5, pp. 487-496

2019

  1. Acute heart failure and adverse events associated with the presence of renal dysfunction and hyperkalaemia. EAHFE- renal dysfunction and hyperkalaemia

    European Journal of Internal Medicine, Vol. 67, pp. 89-96

  2. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1353-1365

  3. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort

    European Journal of Heart Failure, Vol. 21, Núm. 10, pp. 1231-1244

  4. Editor’s Choice– Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 7, pp. 667-680